Klinik am See
- Address
- lock Available on a paid plan
Klinik am See - Cardiovascular Research Center
Klinik am See is a specialized clinical research facility dedicated to advancing treatments for cardiovascular conditions, with particular expertise in heart failure management and therapeutic innovation. The center focuses on evaluating novel pharmacological interventions for patients with cardiac dysfunction, working to improve outcomes for individuals living with complex cardiovascular diseases.
- Heart failure treatment optimization and dose-finding studies
- Evaluation of novel therapeutic agents in reduced ejection fraction populations
- Biomarker-guided therapy assessment using NT-proBNP monitoring
The research team at Klinik am See specializes in proof-of-concept studies that bridge early drug development and clinical application, particularly in patients with symptomatic heart failure and LVEF < 50%. Their work emphasizes rigorous dose-response evaluation and integration of emerging therapies with standard-of-care treatments, including ACEI/ARB and sacubitril/valsartan regimens, contributing valuable evidence to the cardiovascular medicine field.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 27 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Novartis Pharma AG1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinik am See
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy of Inclisiran Sodium Versus Bempedoic Acid in LDL-C Reduction in Atherosclerotic Cardiovascular Disease Patients | Novartis Pharma GmbH | Phase III | Not Recruiting | Jun 2024 | Jan 2026 |
IMP list
lock Showing 1 of 27 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pelacarsen | 2 | Unknown | 2020-03-06 | 2026-05-11 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.